Dietary intakes of flavonols, flavones and isoflavones by Japanese women and the inverse correlation between quercetin intake and plasma LDL cholesterol concentration, J. Nutr, vol.130, pp.2243-2250, 2000. ,
Technique of emulsification,in: Emulsions: Theory and Practice, p.470, 1965. ,
Flavonoids Affect Actin Functions in Cytoplasm and Nucleus, Biophysical Journal, vol.93, issue.8, pp.2767-2780, 2007. ,
DOI : 10.1529/biophysj.107.107813
Degradation of kinetically-stable o/w emulsions, Advances in Colloid and Interface Science, vol.107, issue.2-3, pp.125-155, 2004. ,
DOI : 10.1016/S0001-8686(03)00115-5
Antimetastatic potential of fisetin involves inactivation of the PI3K/Akt and JNK signaling pathways with downregulation of MMP-2/9 expressions in prostate cancer PC-3 cells, Molecular and Cellular Biochemistry, vol.61, issue.1-2, pp.169-180, 2010. ,
DOI : 10.1007/s11010-009-0217-z
Flavonoids as DNA Topoisomerase Antagonists and Poisons: Structure-Activity Relationships, Journal of Natural Products, vol.58, issue.2, pp.217-225, 1995. ,
DOI : 10.1021/np50116a009
Parenteral microemulsions: An overview, International Journal of Pharmaceutics, vol.355, issue.1-2, pp.19-30, 2008. ,
DOI : 10.1016/j.ijpharm.2008.01.004
Permanent cell line expressing human factor VIII-related antigen established by hybridization., Proceedings of the National Academy of Sciences, vol.80, issue.12, pp.3734-3737, 1983. ,
DOI : 10.1073/pnas.80.12.3734
Top ten considerations in the development of parenteral emulsions, Pharmaceutical Science & Technology Today, vol.2, issue.4, 1999. ,
DOI : 10.1016/S1461-5347(99)00141-8
Flavonoids, dietary-derived inhibitors of cell proliferation and in vitro angiogenesis, Cancer Res, vol.57, pp.2916-2921, 1997. ,
Nonclinical Vehicle Use in Studies by Multiple Routes in Multiple Species, International Journal of Toxicology, vol.36, issue.9, pp.499-521, 2006. ,
DOI : 10.1080/10915810600961531
Pharmacokinetics and pharmacodynamics of chlorambucil delivered in parenteral emulsion, International Journal of Pharmaceutics, vol.360, issue.1-2, pp.115-121, 2008. ,
DOI : 10.1016/j.ijpharm.2008.04.027
Noncompartmental Analysis Based on Statistical Moment Theory, pp.409-417, 1982. ,
DOI : 10.1201/b14095-12
A Novel Camptothecin Derivative Incorporated in Nano-Carrier Induced Distinguished Improvement in Solubility, Stability and Anti-tumor Activity Both In Vitro and In Vivo, Pharmaceutical Research, vol.3, issue.109, pp.926-935, 2009. ,
DOI : 10.1007/s11095-008-9795-9
The biochemistry and medical significance of the flavonoids, Pharmacology & Therapeutics, vol.96, issue.2-3, pp.67-202, 2002. ,
DOI : 10.1016/S0163-7258(02)00298-X
A novel emulsifier, Labrasol, enhances gastrointestinal absorption of gentamicin, Life Sciences, vol.69, issue.24, pp.2899-2910, 2001. ,
DOI : 10.1016/S0024-3205(01)01375-3
Nutraceutical inhibitors of urokinase: Potential applications in prostate cancer prevention and treatment, Oncology Reports, vol.16, pp.341-346, 2006. ,
DOI : 10.3892/or.16.2.341
Disposition characteristics of emulsions and incorporated drugs after systemic or local injection, Advanced Drug Delivery Reviews, vol.45, issue.1, pp.77-88, 2000. ,
DOI : 10.1016/S0169-409X(00)00102-2
A Novel Dietary Flavonoid Fisetin Inhibits Androgen Receptor Signaling and Tumor Growth in Athymic Nude Mice, Cancer Research, vol.68, issue.20, pp.8555-8563, 2008. ,
DOI : 10.1158/0008-5472.CAN-08-0240
Japanese Intake of Flavonoids and Isoflavonoids from Foods, Journal of Epidemiology, vol.8, issue.3, pp.168-175, 1998. ,
DOI : 10.2188/jea.8.168
Self-emulsifying drug delivery systems (SEDDS) of coenzyme Q10: formulation development and bioavailability assessment, International Journal of Pharmaceutics, vol.212, issue.2, pp.233-246, 2001. ,
DOI : 10.1016/S0378-5173(00)00614-1
Design and Development of Nanovehicle-Based Delivery Systems for Preventive or Therapeutic Supplementation with Flavonoids, Current Medicinal Chemistry, vol.17, issue.1, pp.74-95, 2010. ,
DOI : 10.2174/092986710789957760
Flavonoids as Anticancer Agents: Structure-Activity Relationship Study, Current Medicinal Chemistry-Anti-Cancer Agents, vol.2, issue.6, pp.691-714, 2002. ,
DOI : 10.2174/1568011023353714
Crystal Structure of a Human Cyclin-Dependent Kinase 6 Complex with a Flavonol Inhibitor, Fisetin, Journal of Medicinal Chemistry, vol.48, issue.3, pp.737-743, 2005. ,
DOI : 10.1021/jm049353p
The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer, Pharmacol. Rev, vol.52, pp.673-751, 2000. ,
Development of a liposomal formulation of the natural flavonoid fisetin, International Journal of Pharmaceutics, vol.423, issue.1, pp.69-76, 2012. ,
DOI : 10.1016/j.ijpharm.2011.04.066
SolEmulsnovel technology for the formulation of i.v. emulsions with poorly soluble drugs, Int. J, p.550, 2004. ,
Lymphatic targeting with nanoparticulate system Adv, 2001. ,
Cremophor-free intravenous microemulsions for paclitaxel I: formulation, cytotoxicity and hemolysis, Int. J. Pharm, vol.349, pp.555-108, 2008. ,
Chromosomal malsegregation and micronucleus induction in vitro by the DNA topoisomerase II inhibitor fisetin, Mutation Research/Genetic Toxicology and Environmental Mutagenesis, vol.582, issue.1-2, pp.79-86, 2005. ,
DOI : 10.1016/j.mrgentox.2005.01.002
Effect of Oil-in-Water Submicron Emulsion Surface Charge on Oral Absorption of a Poorly Water-Soluble Drug in Rats, Drug Delivery, vol.50, issue.8, 2008. ,
DOI : 10.1016/S0378-4347(00)81271-2
Pharmacokinetics and tissue distribution of etoposide delivered in long circulating parenteral emulsion, Journal of Drug Targeting, vol.55, issue.13, pp.543-553, 2005. ,
DOI : 10.1248/cpb.42.646
Engineering of Nanoemulsions for Drug Delivery, Current Drug Delivery, vol.2, issue.4, pp.297-310, 2005. ,
DOI : 10.2174/156720105774370267
Different Tissue Distribution of Paclitaxel With Intravenous and Intraperitoneal Administration, Journal of Surgical Research, vol.155, issue.1, pp.142-146, 2009. ,
DOI : 10.1016/j.jss.2008.06.049
Solubilizing Excipients in Oral and Injectable Formulations, Pharmaceutical Research, vol.21, issue.2, pp.201-230, 2004. ,
DOI : 10.1023/B:PHAM.0000016235.32639.23